Views & Analysis

Oncology
CAR-TCR 2023 – Mindy Miller

CAR-TCR 2023 – Mindy Miller

As more cell therapies are approved and the category emerges, there’s also an increased need for the technology that enables cell therapy development.

Oncology
CAR-TCR 2023 – Matt Lakelin

CAR-TCR 2023 – Matt Lakelin

Innovative, advanced therapies have enormous promise, but also come with a host of logistical problems that innovators underestimate at their own peril.

Oncology
CAR-TCR 2023 – Tim McGuire

CAR-TCR 2023 – Tim McGuire

As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.

Oncology
cancer treatment

Elements in precision oncology

Validating the regulatory expectations on evidential requirements for predictive biomarkers is not a trivial process, but quite conceptually challenging.